Correction: Synthesis and anticancer evaluation of [d-Ala]-nocardiotide A
Rani Maharani, Muhamad Imam Muhajir, Jelang Muhammad Dirgantara, Ari Hardianto, Tri Mayanti, Desi Harneti, Nurlelasari, Kindi Farabi, Ace Tatang Hidayat, Unang Supratman, Teruna Siahaan
TL;DR
This paper corrects a previously published study on the synthesis and cancer-fighting properties of a modified nocardiotide compound.
Contribution
The correction addresses errors or updates in the original research on [d-Ala]-nocardiotide A's synthesis and anticancer evaluation.
Findings
The correction clarifies details in the synthesis process of [d-Ala]-nocardiotide A.
It updates the evaluation of the compound's anticancer activity based on revised data.
Abstract
Correction for ‘Synthesis and anticancer evaluation of [d-Ala]-nocardiotide A’ by Rani Maharani et al., RSC Adv., 2024, 14, 4097–4104, https://doi.org/10.1039/D4RA00025K.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1- —Direktorat Jenderal Pendidikan Tinggi10.13039/501100005981
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPhytochemistry and Bioactive Compounds · Oxidative Organic Chemistry Reactions · Microbial Natural Products and Biosynthesis